Adrenal gland - Strong INHA immunostaining in all cells of an adrenocortical adenoma.
Adrenal gland - Strong INHA immunostaining in an adrenocortical carcinoma. Immunostaining is reduced in an area of necrosis.
Adrenal gland - Strong INHA immunostaining in most cells of an adrenocortical adenoma. A fraction of cells do not stain, however (mosaic pattern).
Adrenal gland - Weak to moderate INHA immunostaining about 70% of the cells of an adrenocortical adenoma.
Breast - INHA negative invasive breast cancer of no special type (NST).
Colon - Colorectal adenocarcinoma with focal weak to moderat INHA immunostaining (<5% of cells).
Esophagus - INHA negative esophageal squamous cell carcinoma.
Kidney - INHA negative clear cell renal cell carcinoma.
Kidney - Moderate to strong INHA immunostaining in a clear cell renal cell carcinoma.
Larynx - INHA negative squamous cell carcinoma.
Liver - Moderate to strong INHA immunostaining in about 50% of the tumor cells of a cholangiocellular carcinoma.
Lung - Strong INHA positivity in an adenocarcinoma of the lung.
Ovary - INHA negative serous high-grade carcinoma. Scattered stroma cells show strong INHA positivity.
Pancreas - INHA negative adenocarcinoma.
Pancreas - Moderate to strong INHA immunostaining in a pancreatic acinar cell carcinoma.
Pancreas - Strong INHA immunostaining in the vast majority of the tumor cells of a neuroendocrine tumor.
Penis - INHA positivity of variable intensity (mosaic pattern) in a penile squamous cell carcinoma.
Prostate - INHA negative prostatic adenocarcinoma (Gleason 3+3=6).
Skin - INHA negative Merkel cell carcinoma.
Soft tissues - Granular cell tumor with strong INHA immunostaining.
Stomach - INHA negative gastric adenocarcinoma.
Testis - INHA negative seminoma.
Thyroid - INHA negative papillary carcinoma.
Urinary bladder - INHA negative muscle-invasive urothelial carcinoma.
Urinary bladder - Muscle-invasive urothelial carcinoma with focal strong INHA immunostaining (<5% of cells).